Related Experiment Video
Updated: Apr 21, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant
Paraskevi Gkeka1, Thomas Evangelidis1, Maria Pavlaki2
1Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Abstract:
The PIK3CA gene is one of the most frequently mutated oncogenes in human cancers. It encodes p110α, the catalytic subunit of phosphatidylinositol 3-kinase alpha (PI3Kα), which activates signaling cascades leading to cell proliferation, survival, and cell growth. The most frequent mutation in PIK3CA is H1047R, which results in enzymatic overactivation. Understanding how the H1047R mutation causes the enhanced activity of the protein in atomic detail is central to developing mutant-specific therapeutics for cancer. To this end, Surface Plasmon Resonance (SPR) experiments and Molecular Dynamics (MD) simulations were carried out for both wild-type (WT) and H1047R mutant proteins. An expanded positive charge distribution on the membrane binding regions of the mutant with respect to the WT protein is observed through MD simulations, which justifies the increased ability of the mutated protein variant to bind to membranes rich in anionic lipids in our SPR experiments. Our results further support an auto-inhibitory role of the C-terminal tail in the WT protein, which is abolished in the mutant protein due to loss of crucial intermolecular interactions. Moreover, Functional Mode Analysis reveals that the H1047R mutation alters the twisting motion of the N-lobe of the kinase domain with respect to the C-lobe and shifts the position of the conserved P-loop residues in the vicinity of the active site. These findings demonstrate the dynamical and structural differences of the two proteins in atomic detail and propose a mechanism of overactivation for the mutant protein. The results may be further utilized for the design of mutant-specific PI3Kα inhibitors that exploit the altered mutant conformation.
Insights
The PIK3CA H1047R mutation enhances phosphatidylinositol 3-kinase alpha (PI3Kα) activity by altering protein dynamics and membrane binding. This study reveals atomic-level differences, aiding the development of targeted cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The PIK3CA gene is frequently mutated in cancers, encoding p110α, a key component of PI3Kα signaling.
- The H1047R mutation is common and leads to overactivation of PI3Kα, driving cell proliferation and survival.
Purpose of the Study:
- To elucidate the atomic-level mechanisms behind the H1047R mutation-induced overactivation of PI3Kα.
- To provide insights for developing mutant-specific cancer therapeutics.
Main Methods:
- Surface Plasmon Resonance (SPR) experiments to assess protein-lipid interactions.
- Molecular Dynamics (MD) simulations to analyze protein structure and dynamics.
- Functional Mode Analysis to study protein domain movements.
Main Results:
- MD simulations revealed altered charge distribution on membrane-binding regions of the H1047R mutant, enhancing anionic lipid binding (confirmed by SPR).
- The C-terminal tail's auto-inhibitory role in wild-type PI3Kα was abolished in the mutant.
- H1047R mutation altered kinase domain dynamics, including N-lobe/C-lobe twisting and P-loop positioning.
Conclusions:
- The H1047R mutation causes PI3Kα overactivation through altered protein dynamics, membrane interactions, and loss of auto-inhibition.
- Understanding these atomic-level changes is crucial for designing targeted PI3Kα inhibitors for cancer treatment.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation